Elixinol Wellness Ltd (AU:EXL) — Market Cap & Net Worth
Market Cap & Net Worth: Elixinol Wellness Ltd (EXL)
Elixinol Wellness Ltd (AU:EXL) has a market capitalization of $2.05 Million (AU$2.90 Million) as of May 6, 2026. Listed on the AU stock exchange, this Australia-based company holds position #29662 globally and #1757 in its home market, demonstrating a -12.50% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Elixinol Wellness Ltd's stock price AU$0.01 by its total outstanding shares 413987731 (413.99 Million). Analyse Elixinol Wellness Ltd (EXL) cash conversion ratio to see how efficiently the company converts income to cash.
Elixinol Wellness Ltd Market Cap History: 2018 to 2026
Elixinol Wellness Ltd's market capitalization history from 2018 to 2026. Data shows change from $632.04 Million to $2.05 Million (-46.37% CAGR).
Elixinol Wellness Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Elixinol Wellness Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.74x
Elixinol Wellness Ltd's market cap is 0.74 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $632.04 Million | $37.13 Million | -$860.00K | 17.02x | N/A |
| 2019 | $142.86 Million | $30.71 Million | -$80.62 Million | 4.65x | N/A |
| 2020 | $51.26 Million | $15.01 Million | -$104.51 Million | 3.42x | N/A |
| 2021 | $21.09 Million | $9.34 Million | -$17.02 Million | 2.26x | N/A |
| 2022 | $6.15 Million | $7.05 Million | -$10.57 Million | 0.87x | N/A |
| 2023 | $3.52 Million | $8.27 Million | -$7.51 Million | 0.43x | N/A |
| 2024 | $11.13 Million | $14.96 Million | -$1.72 Million | 0.74x | N/A |
Competitor Companies of EXL by Market Capitalization
Companies near Elixinol Wellness Ltd in the global market cap rankings as of May 6, 2026.
Key companies related to Elixinol Wellness Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #497 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #524 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
- Zoetis Inc (NYSE:ZTS): Ranked #531 globally with a market cap of $49.66 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #571 globally with a market cap of $45.88 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #497 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #524 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.29 Billion | CN¥53.88 |
| #531 | Zoetis Inc | NYSE:ZTS | $49.66 Billion | $112.68 |
| #571 | GALDERMA GROUP AG | NYSE:GALDY | $45.88 Billion | $41.87 |
Elixinol Wellness Ltd Historical Marketcap From 2018 to 2026
Between 2018 and today, Elixinol Wellness Ltd's market cap moved from $632.04 Million to $ 2.05 Million, with a yearly change of -46.37%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$2.05 Million | -22.22% |
| 2025 | AU$2.64 Million | -76.32% |
| 2024 | AU$11.13 Million | +216.67% |
| 2023 | AU$3.52 Million | -42.86% |
| 2022 | AU$6.15 Million | -70.83% |
| 2021 | AU$21.09 Million | -58.86% |
| 2020 | AU$51.26 Million | -64.12% |
| 2019 | AU$142.86 Million | -77.40% |
| 2018 | AU$632.04 Million | -- |
End of Day Market Cap According to Different Sources
On May 5th, 2026 the market cap of Elixinol Wellness Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.05 Million USD |
| MoneyControl | $2.05 Million USD |
| MarketWatch | $2.05 Million USD |
| marketcap.company | $2.05 Million USD |
| Reuters | $2.05 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Elixinol Wellness Ltd
Elixinol Wellness Limited, a holding company, provides healthy products in Australia, the Americas, and internationally. The company provides human nutrition, human wellness, pet wellness, and superfood ingredients under Hemp Foods Australia, Mt Elephant, The Healthy Chef, Soul Foods, Ananda Equine, and Field Day brands. It distributed through grocery, wholesale, and e-commerce channels for white… Read more